secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2025-03-10T23:59:59+00:00
Accession:  0001729149-25-000055
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed posts record Q4 revenue $60.7M; full year net revenue $224.3M; issues 2025 guidance
--------------------------------------------------------------------------------

- Q4 net revenue $60.7M (+20% YoY); full year $224.3M (+23% YoY).
- Q4 diluted EPS $0.10 (net income $4.3M); full year EPS $0.28.
- Adjusted EBITDA Q4 $14.2M; full year record $51.1M.
- Ventilator patients 11,795 (+14% YoY); PAP therapy 21,338 (+43% YoY).
- Issued fiscal 2025 guidance; specific targets not included in filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914925000055/0001729149-25-000055-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914925000055/vmd-20250310.htm
  HTML page:      https://secwatch.observer/filing/0001729149-25-000055

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer